Following the latest in microcap news, articles, interviews, and more

Pharmaceuticals & Biotech

ULURU Inc. Announces Conference Call To Discuss Financial Results For The Fourth Quarter And Year Ending December 31, 2015

ADDISON, Texas, March 23, 2016 /PRNewswire/ — ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the fourth quarter and year ending December 31, 2015 financial results and to provide a general business update on April 1, 2016 at 8:30 a.m. Eastern Time. To participate in the conference call please […]

Imprimis Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, March 16, 2016 /PRNewswire/ — Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), (“Imprimis” or the “company”), a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, announced today that it has completed the previously announced public offering of common stock.  Imprimis sold 2.9 million shares in the offering and an additional 435,000 […]

Cannabis Science Moves Forward Clinical Drug Development With Confidence as GW Pharma Announces Positive Results With Its CBD-Based Epilepsy Formulation

COLORADO SPRINGS, CO–(Marketwired – Mar 14, 2016) – Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, applauds the recent success of GW Pharmaceuticals in their phase three testing of a CBD-based product designed to treat patients with a rare form of epilepsy. The successful trials in Europe […]

Actinium Pharmaceuticals Initiates Pursuit of EU Orphan Designation for Iomab-B

NEW YORK, NY–(Marketwired – March 11, 2016) – Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or the “Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has engaged a leading European-based regulatory affairs consulting firm to pursue orphan medicines designation by the European Medicines Agency […]

Roche launches new chromogen for cancer research

TUCSON, Ariz., March 11, 2016 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the DISCOVERY Yellow Kit1, the newest addition to the comprehensive collection of VENTANA modular-based detection kits to aid in the identification and profiling of cancer biomarkers and tumor cell populations. DISCOVERY Yellow is an alkaline phosphatase-based detection chemistry […]

OptimizeRx Sets Fourth Quarter and Full Year 2015 Conference Call for Tuesday, March 15, 2016 at 5:30 p.m. ET

ROCHESTER, MI–(Marketwired – March 09, 2016) –  OptimizeRx Corp. (OTCQB: OPRX), a software company whose premier content-delivery platform enables pharmaceutical companies to provide on-demand patient-savings and support services right at point of prescribe, will hold a conference call on Tuesday, March 15, 2016 at 5:30 p.m. Eastern time to discuss results for the fourth quarter […]

Cannabis Science Announces Update on Issuance of Dividends

The Company Continues Open Dialogue With FINRA and Remains Diligent as Issuance Passes Through Regulatory Process to Finalization COLORADO SPRINGS, CO–(Marketwired – Jan 11, 2016) – Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced an update on its dividend process. The Company is actively working […]

Upcoming Corporate Presentations In San Francisco

SAN DIEGO, Jan. 8, 2016 /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a clinical-stage oncology company developing new treatments for cancer and associated pain, announced today that Dr. Henry Ji, President and Chief Executive Officer, will provide a corporate overview at three upcoming healthcare conferences. Dr. Ji will present: –  Late stage biosimilar and biobetter antibody programs, including […]

Copyright © EquityBuzz 2016